Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Retained Earnings (2016 - 2025)

Amphastar Pharmaceuticals has reported Retained Earnings over the past 13 years, most recently at $666.9 million for Q4 2025.

  • Quarterly results put Retained Earnings at $666.9 million for Q4 2025, up 17.25% from a year ago — trailing twelve months through Dec 2025 was $666.9 million (up 17.25% YoY), and the annual figure for FY2025 was $666.9 million, up 17.25%.
  • Retained Earnings for Q4 2025 was $666.9 million at Amphastar Pharmaceuticals, up from -$5.3 million in the prior quarter.
  • Over the last five years, Retained Earnings for AMPH hit a ceiling of $666.9 million in Q4 2025 and a floor of -$9.9 million in Q3 2022.
  • Median Retained Earnings over the past 5 years was $62.7 million (2021), compared with a mean of $217.5 million.
  • Biggest five-year swings in Retained Earnings: plummeted 106.67% in 2022 and later skyrocketed 7182.51% in 2025.
  • Amphastar Pharmaceuticals' Retained Earnings stood at -$6.8 million in 2021, then decreased by 27.48% to -$8.6 million in 2022, then surged by 4845.69% to $409.3 million in 2023, then surged by 38.98% to $568.8 million in 2024, then increased by 17.25% to $666.9 million in 2025.
  • The last three reported values for Retained Earnings were $666.9 million (Q4 2025), -$5.3 million (Q3 2025), and $625.1 million (Q2 2025) per Business Quant data.